New Diagnostic Criteria for Alzheimer’s Disease

Abstract

Bruno Dubois is currently Professor of Neurology at the Neurological Institute of the Salpêtrière Hospital in Paris, University Pierre & Marie Curie. He is Director of the Institute for Memory and Alzheimer Disease and the Research INSERM Unit on Cognition and Neuroimaging in Brain Diseases at the Institut du Cerveau et de la Moelle Epinière at the Salpêtrière Hospital. He is President of the Scientific Committee of France-Alzheimer and of International Fund Raising for Alzheimer’s disease, consultant for the Human Frontier Program and Expert of the French Agency of Drugs. He is a member of the European Alzheimer Disease Consortium (Therapeutics and Intervention Studies). He has published articles on anatomical and biochemical studies on the central cholinergic systems in rodents and humans; on cognitive neuropharmacology and on neuropsychology in patients with dementia, with special reference to memory and executive functions. Dr Dubois recently organized an expert consensus on the new criteria for Alzheimer’s disease and a task force on the new criteria for Parkinson’s disease dementia. He is principal or co-investigator of a number of research programmes focusing on Alzheimer’s disease, mild cognitive impairment and dementia in Parkinson’s disease.